laut Oder später Stengel aminosalicylates mechanism of action Osten Graph Verführen
A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug | SpringerLink
Aminosalicylates
Classical and recent advances in the treatment of inflammatory bowel diseases - Brazilian Journal of Medical and Biological Research
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology
Mesalamine | C7H7NO3 - PubChem
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
5-ASA | IBD Clinic
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Drugs used in IBD and biological and immune therapy of IBD ” - ppt download
Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease - Gastroenterology Clinics
5-aminosalicylates [TUSOM | Pharmwiki]
Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evid | DDDT
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases | Pharmacology
Biologics | Free Full-Text | Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions | HTML
Prof. Hanan Hagar Pharmacology Unit College of Medicine - ppt download
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Inflammatory Bowel Disease | NEJM
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD. - ppt download
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
The long journey of salicylates in ulcerative colitis: The past and the future - ScienceDirect
Frontiers | Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice | Immunology